MK-801 inhibits the cortical increase in IGF-1, IGFBP-2 and IGFBP-4 expression following trauma

NeuroReport

Volumn 8, Issue 2, 1997, Pages 455-460

  Sandberg Nordqvist, Ann Christin ^a   Holmin, Staffan ^a   Nilsson, Mia ^a   Mathiesen, Tiit ^a   Schalling, Martin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CNQX; Gene regulation; Glutamate receptors; Head trauma; IGF binding proteins; In situ hybridization; Insulin like growth factor 1 (IGF 1); MK 801; mRNA; Rat

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; GENE EXPRESSION; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030890895     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199701200-00016     Document Type: Article

References (26)

1. Ayer-LeLievre C, Stanlbom P-A and Sara VR. Development 111, 105-115 (1991).
2. Bondy C, Werner H, Roberts CT Jr et al. Neuroscience 46, 909-923 (1992).
3. Aguado F, Rodrigo J, Cacicedo L et al. J Mol Endocrin 11, 231-239 (1993).
4. Shimasaki S and Ling N. Growth Factor Res 3, 243-266 (1991).
5. Lee W-H, Clemens JA and Bondy CA. Mol Cell Neurosci 3, 36-43 (1992).
6. Klempt M, Klempt ND and Gluckman PD. Mol Brain Res 17, 347-350 (1993).
7. Breese CR, D'Costa A, Rollins YD et al. J Comp Neurol 369, 388-404 (1996).
8. Sandberg Nordqvist A-C, von Holst H, Holmin S et al. Mol Brain Res 38, 285-293 (1996).
9. Guan J, Williams C, Gunning M et al. J Cerebr Blood Flow Metab 13, 609-616 (1993).
10. Watkins JC and Evans RH. Annu Rev Pharmacol Toxicol 21, 165-204 (1981).
11. Faden AJ, Demediuk P, Scott Panter S et al. Science 244, 798-800 (1989).
12. Watkins JC. Selective antagonists define sub-classes of excitatory amino acid receptors. In: Goodman EC and Iversen LL, eds. Fast and Slow Chemical Signalling in the Nervous System. Oxford: Oxford University Press, 1986: 89-105.
13. Isackson PJ. Curr Opin Neurobiol 5, 350-357 (1995).
14. Wong EH, Kemp JA, Priestley T et al. Proc Natl Acad Sci USA 83, 7104-7108 (1986).
15. Woodruff GN, Foster AC, Gill R et al. Neuropharmacology 26, 903-909 (1987).
16. Lynch JJ, YU SP, Canzoniero MT et al. J Pharmacol Exp Ther 273, 554-560 (1995).
17. Feeney DM, Boyeson MG, Linn RT et al. Brain Res 211, 67-77 (1981).
18. Brown AL, Chiarotti L, Orlowskui CC et al. J Biol Chem 264, 5148-5154 (1989).
19. Shimasaki S, Uchiyama F, Shimonaka M et al. Mol Endocrinol 4, 1451-1458 (1990).
20. Bullock R. Ann NY Acad Sci 765, 272-278 (1995).
21. Sara VR, Sandberg Nordqvist A-C, Carlsson-Skwirut C et al. Neuroactive products of IGF-1 and IGF-2 gene expression in the CNS. In: Raizada MK, LeRoith D, eds. Molecular Biology and Physiology of Insulin and Insulin-like Growth Factors. New York: Plenum Press, 1991: 439-448.
22. Ikeda T, Waldbillig RJ and Puro DG. Brain Res 686, 87-92 (1995).
23. Bourguiǵnon JP, Alvarez Gonzalez ML, Gerard A et al. Endocrinology 134, 1589-1592 (1994).
24. Liu X, Yao D-L, Bondy CA et al. Mol Cell Neurosci 5, 418-430 (1994).
25. Yao DL, Bondy CA, Bernner M et al. J Neurosci Res 40, 647-659 (1995).
26. Ffrench-Mullen JMH and Rogawski MA. J Physiol 456, 85-105 (1992).